Cargando…
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
OBJECTIVES: Hand osteoarthritis (OA) is a condition characterised by cartilage degradation and frequently erosive changes. Analgesics and non-steroidal anti-inflammatory drugs are used for symptomatic relief but are often poorly tolerated or contraindicated. Previous publications suggest hydroxychlo...
Autores principales: | Kedor, Claudia, Detert, Jacqueline, Rau, Rolf, Wassenberg, Siegfried, Listing, Joachim, Klaus, Pascal, Braun, Tanja, Hermann, Walter, Weiner, Stefan Markus, Buttgereit, Frank, Burmester, Gerd R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256837/ https://www.ncbi.nlm.nih.gov/pubmed/34215704 http://dx.doi.org/10.1136/rmdopen-2021-001660 |
Ejemplares similares
-
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial
por: Detert, Jacqueline, et al.
Publicado: (2014) -
Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?
por: Buttgereit, Frank, et al.
Publicado: (2015) -
Mechanisms of action of therapeutic exercise for knee and hip OA remain a black box phenomenon: an individual patient data mediation study with the OA Trial Bank
por: Runhaar, Jos, et al.
Publicado: (2023) -
Baseline clinical characteristics of predicted structural and pain progressors in the IMI-APPROACH knee OA cohort
por: van Helvoort, Eefje Martine, et al.
Publicado: (2021) -
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
por: Kloppenburg, Margreet, et al.
Publicado: (2019)